𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Benefits of “the benefit model” in liver transplantation

✍ Scribed by W. Ray Kim; Walter K. Kremers

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
51 KB
Volume
48
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The pediatric end-stage liver disease (P
The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients
✍ Neal R. Barshes; Timothy C. Lee; Ian W. Udell; Christine A. O'Mahoney; Saul J. K 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 1 views

The pediatric end-stage liver disease (PELD) model accurately estimates 90-day waitlist mortality for pediatric liver transplant candidates, but it has been unclear if PELD can identify patients who will derive survival benefit from undergoing liver transplantation (LT), if it correlates with posttr

Portal vein thrombosis and liver transpl
Portal vein thrombosis and liver transplant survival benefit
✍ Michael J. Englesbe; Douglas E. Schaubel; Shijie Cai; Mary K. Guidinger; Robert 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

Portal vein thrombosis (PVT) complicates the liver transplant operation and potentially affects waiting list survival. The implications on calculations of survival benefit, which balance both waiting list and posttransplant survival effects of PVT, have not been determined. The objective of this stu

Liver transplant recipient survival bene
Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era
✍ Carl L. Berg; Robert M. Merion; Tempie H. Shearon; Kim M. Olthoff; Robert S. Bro 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 1 views

Receipt of a living donor liver transplant (LDLT) has been associated with improved survival compared with waiting for a deceased donor liver transplant (DDLT). However, the survival benefit of liver transplant has been questioned for candidates with Model for Endstage Liver Disease (MELD) scores <1

Microsurgery in a rat lung transplant mo
Microsurgery in a rat lung transplant model: Analysis of benefit
✍ Osvaldo J. Yano; Robin Baradarian; Eugene S. Kim; Tami J. Smith; Mark L. Smith; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB

With the use of microsurgery, we have developed a method of measuring hemodynamic parameters in a rat not possible with previous technology. Three groups of rats were studied: a chemically induced pulmonary hypertensive group (PH); a chemically induced pulmonary hypertensive group treated with singl

Effect of pretransplant serum creatinine
Effect of pretransplant serum creatinine on the survival benefit of liver transplantation
✍ Pratima Sharma; Douglas E. Schaubel; Mary K. Guidinger; Robert M. Merion 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views

More candidates with creatinine levels Ն 2 mg/dL have undergone liver transplantation (LT) since the implementation of Model for End-Stage Liver Disease (MELD)-based allocation. These candidates have higher posttransplant mortality. This study examined the effect of serum creatinine on survival bene